Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage

NCT03390530 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Closed by PI prior to approval

Conditions

Intraventricular Hemorrhage of Prematurity

Interventions

DRUG: Thyroxine
DRUG: Placebo

Sponsor

Albert Einstein College of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]